Evidence map›Paper›PMID 33842415›Full record

ArticleFrontiers in public health2021

Analysis of Epidemiological and Clinical Characteristics of COVID-19 in Northwest Mexico and the Relationship Between the Influenza Vaccine and the Survival of Infected Patients.

Uriel A Angulo-Zamudio, Francisco M Martínez-Villa, Nidia Leon-Sicairos, Hector Flores-Villaseñor, Jorge Velazquez-Roman, Abraham Campos-Romero, Jonathan Alcántar-Fernández, Francisco Urrea, Secundino Muro-Amador, Julio Medina-Serrano and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Epidemiological and clinical characteristics of pregnant women and neonates with COVID-19 in Northwest Mexico.American journal of reproductive immunology (New York, N.Y. : 1989) · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Uriel A Angulo-ZamudioCentro de Investigación Aplicada a la Salud Pública (CIASaP), School of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Francisco M Martínez-VillaPrograma de Maestría en Ciencias en Biomedicina Molecular, Autonomous University of Sinaloa (UAS), Culiacan, Mexico.
Nidia Leon-SicairosCentro de Investigación Aplicada a la Salud Pública (CIASaP), School of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Hector Flores-VillaseñorCentro de Investigación Aplicada a la Salud Pública (CIASaP), School of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Jorge Velazquez-RomanCentro de Investigación Aplicada a la Salud Pública (CIASaP), School of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Abraham Campos-RomeroSalud Digna A.C., Culiacán, Mexico.
Jonathan Alcántar-FernándezSalud Digna A.C., Culiacán, Mexico.
Francisco UrreaHospital Regional, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Culiacán, Mexico.
Secundino Muro-AmadorCentro de Investigación Aplicada a la Salud Pública (CIASaP), School of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Julio Medina-SerranoCoordinación en Investigación en Salud, Órgano de Operación Administrativa Desconcentrada (OOAD), Instituto Mexicano del Seguro Social (IMSS), Culiacan Sinaloa, Mexico.
Jesus J Martinez-GarciaCentro de Investigación Aplicada a la Salud Pública (CIASaP), School of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Jaime Sanchez-CuenCentro de Investigación Aplicada a la Salud Pública (CIASaP), School of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Jorge Angulo-RochaThe Women's Hospital, Secretariat of Health, Culiacan, Mexico.
Adrian Canizalez-RomanCentro de Investigación Aplicada a la Salud Pública (CIASaP), School of Medicine, Autonomous University of Sinaloa, Culiacan, Mexico.
Autonomous University of Sinaloa · MXPediatric Hospital of Sinaloa · MXInstitute for Social Security and Services for State Workers · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first cases of unexplained pneumonia were reported in Wuhan, China, in December of 2019. Later, a novel coronavirus (SARS-CoV-2) was identified as the causal agent of pneumonia. This virus has since spread to more than 180 countries and has been declared a pandemic by the World Health Organization. Herein, we aimed to determine the epidemiological and clinical characteristics of symptomatic patients with coronavirus disease 2019 (COVID-19) and the relationship between the influenza vaccine with a lower risk of severe COVID-19 infection in the state of Sinaloa. We collected demographic and clinical data of 4,040 patients with acute respiratory infections across Sinaloa state hospitals from February 28 to May 15, 2020. The prevalence of COVID-19 among hospitalized patients with respiratory symptoms in Sinaloa showed 45.2% of men were more affected than women (

Indexed as

AdultComorbidityCoughCOVID-19Diabetes Mellitus, Type 2FemaleFeverHumansHypertensionInfluenza VaccinesMaleMexicoMiddle AgedObesitySurvival AnalysisInfluenza Vaccinesclinical characteristicsCOVID-19epidemiologicalinfluenza vaccineMexico

Identifiers

PMID33842415
PMCPMC8026856
OpenAlexW3141366572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.